NRx Pharmaceuticals (NRXP) is developing KETAFREE, a ketamine-based treatment that could become a commercial success if it gains FDA approval. The company also benefits from its clinical infrastructure through HOPE Therapeutics, despite currently having a small revenue base. Additional drug candidates like NRX-101 and partnerships such as with GeNeuro provide further growth options. Although NRXP faces a tight cash runway, its valuation holds long-term upside potential, leading to a speculative buy recommendation.
NRx Pharmaceuticals and its ketamine-based treatment development are the focus of this update, with Pluang providing a snapshot of the Health sector market as of Sep 14, 2026 20:12 WIB. Among 91 priced Health-sector US stocks tradable on Pluang, 53 rose and 28 fell today. Notable movers include SMMT (Summit Therapeutics Inc) at USD 18.24 with a 3.93% increase, CTXR (Citius Pharmaceuticals Inc) at USD 0.60 up 3.75%, and MDT (Medtronic PLC) at USD 94.25 rising 3.62%.
WasabiCard, a stablecoin-based global payment provider, engaged in key partnership discussions at TOKEN2049 Singapore 2026, focusing on white-label card issuing, global payouts, and embedded payments. The company highlighted growing demand in APAC fo...
The global next generation antibody therapeutics market is projected to increase from $5.45 billion in 2026 to $5.76 billion by 2035, growing at a CAGR of 1%. Growth is fueled by advances in biotechnology, rising demand for targeted therapies, and in...
The global insurtech market is projected to grow from $14 billion today to $638 billion by 2035, at a compound annual growth rate of 41.45%. This rapid expansion is fueled by the adoption of AI, blockchain, cloud computing, machine learning, IoT, and...
The global market for wiring harnesses and connectors in electric vehicles is projected to grow from $8.53 billion in 2025 to $29.43 billion by 2035, at a CAGR of 12.83%. This growth is fueled by increasing EV production, adoption of battery electric...
The global Decentralized Clinical Trials (DCT) market, valued at $8.8 billion in 2025, is projected to grow to $18.8 billion by 2030, expanding at a CAGR of 13.7%. Growth is fueled by adoption of AI, wearables, cloud platforms, and flexible remote st...
